Alcon Inc.
Climate Impact & Sustainability Data (2021)
Reporting Period: 2021
Environmental Metrics
Total Carbon Emissions:309,083 tCO2e/year (Scope 1 and 2)
Scope 1 Emissions:81,151 tCO2e/year
Scope 2 Emissions:227,933 tCO2e/year (market-based)
Scope 3 Emissions:1,232,428 tCO2e/year (2019 baseline)
Renewable Energy Share:Not disclosed
Total Energy Consumption:2,914,826 GJ/year
Water Consumption:4,864 ML/year
Waste Generated:51,782 tons/year
Carbon Intensity:55 tCO2e/TJ (onsite generated energy); 126 tCO2e/TJ (purchased energy)
ESG Focus Areas
- Brilliant Lives (Access to eye care)
- Brilliant Innovation (Sustainable product development)
- Brilliant Planet (Environmental sustainability)
Environmental Achievements
- Three manufacturing sites achieved GreenCircle zero waste to landfill certification.
- 7% decrease in energy intensity compared to 2019 baseline.
- Approximately 8,400 metric tons of CO2e avoided through energy-saving projects.
- Approximately 76% of operational waste recycled.
Social Achievements
- More than 5,000 surgeons trained through Phaco Development program, resulting in over 7 million sight-enhancing or restoring cataract procedures.
- Over $11 million in Alcon Cares product and equipment donations, supporting 73 medical missions and treating over 40,000 patients.
- ~2,800 associates volunteered in 137 partner organization events.
- 35,000+ elementary-aged children screened as part of a pilot Children’s Vision Program.
Governance Achievements
- 99.5% of full-time associates completed Code of Business Conduct training.
- ~13% of U.S. procurement sourced from diverse suppliers.
- Established multi-year diversity and inclusion strategy.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Become carbon neutral across global operations by 2030.
- Divert 100% of non-hazardous waste from landfill at manufacturing sites and distribution centers by 2030.
Short-term Goals:
- Improve vision for 5 million people with untreated cataracts by 2025.
- Provide 150,000 vision screenings to children by 2025.
Environmental Challenges
- COVID-19 pandemic disrupted some ESG initiatives and performance.
- Increased global turnover rates in 2021.
- Increased hazardous waste due to expired product disposal.
Mitigation Strategies
- Continued COVID-19 response hub to provide sites with protocols.
- Maintained retention rates better than top-quartile pharmaceutical/medical device benchmarks.
- Implemented 17 water-saving projects at sites.
- Ongoing site initiatives to reduce non-hazardous waste.
Supply Chain Management
Supplier Audits: 18% of Tier 1 suppliers audited in 2021.
Responsible Procurement
- Alcon Third Party Code of Conduct
- EcoVadis platform to track supplier ESG performance.
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather and natural disasters
Transition Risks
- Regulatory changes (carbon disclosure, carbon tax, etc.)
Opportunities
- Cost savings through energy efficiency initiatives
- Reduced raw material use in manufacturing and packaging.
Reporting Standards
Frameworks Used: GRI, SASB, TCFD
Certifications: ISO 14001
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Green Cell Foam packaging replacement
Awards & Recognition
- GreenCircle zero waste to landfill certification
- Great Place to Work certification
- Top Employer recognition
- DiversityInc Top Noteworthy Company